Cardinal Sees Sterile Manufacturing As Key Component Of Revenue Growth
This article was originally published in The Pink Sheet Daily
Executive Summary
Cardinal is optimistic about demand for its sterile manufacturing service, although it continues to have regulatory problems at its Puerto Rico facility and its Albuquerque plant has taken time to "get into a rhythm." The company announced a restructuring plan expected to improve operating earnings by $500 mil.
You may also be interested in...
Cardinal Fee-For-Service Distribution Margins Lower Than Anticipated
Wholesaler remains optimistic that manufacturers' distribution fees will rise over time due to "built-in escalators" in existing contracts and potential to increase fees during contract renewal.
Cardinal Fee-For-Service Distribution Margins Lower Than Anticipated
Wholesaler remains optimistic that manufacturers' distribution fees will rise over time due to "built-in escalators" in existing contracts and potential to increase fees during contract renewal.
Pharmaceutical Prices Will Increase 6% In 2005, Cardinal Expects
Cardinal predicts that prices for pharmaceutical products will increase an average of 6% in 2005